Fayetteville pharmaceutical development firm BiologicsMD has named David Owens its first CEO. BiologicsMD is a portfolio company of VIC Technology Venture Development, which had previously managed its operations. Most recently, Owens was chief business officer for Novira Therapeutics, an antiviral drug discovery company based in Doylestown, Pa. In March, Novira completed a $25 million Series A financing round. BiologicsMD has developed an osteoporosis treatment, PTH-CBD, that binds to the bone and stimulates new bone growth. “I’m very excited to join the BiologicsMD team at this very important stage in advancing the company’s lead development drug, PTH-CBD, towards the clinic,” Owens said in a news release. “The team and the board have done an excellent job of getting the technology to the pre-clinical stage. Now we will prove that PTH-CBD is a novel and important new tool in treating human disease.” Click here to read the full article from Arkansas Business: BiologicsMD Names David Owens CEO
